Safety Study of Multipotent Progenitor Cells for Immunomodulation Therapy After Liver Transplantation

NCT01841632 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Liver Transplantation

Interventions

DRUG: MultiStem

Sponsor

Prof. Dr. Marc-H. Dahlke, Ph. D.

Collaborators

[object Object]
[object Object]